logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Calcium Channel Blocker class drugs

    FiltersReset Filters
    23 results

    • amlodipine and olmesartan medoxomil

      (AMLODIPINE and OLMESARTAN medoxomil)
      Macleods Pharmaceuticals Limited
      Usage: Amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents, to lower blood pressure and reduce cardiovascular event risks, including strokes and heart attacks. They may also serve as initial therapy for patients needing multiple agents.

    • amlodipine besylate

      (AMLODIPINE BESYLATE)
      Cipla USA Inc.
      Usage: Amlodipine besylate is indicated for treating hypertension to reduce the risk of cardiovascular events and for managing chronic stable angina, vasospastic angina, and angiographically documented coronary artery disease (CAD) to minimize hospitalization and the need for coronary revascularization.

    • amlodipine besylate

      (AMLODIPINE BESYLATE)
      Epic Pharma, LLC
      Usage: Amlodipine Besylate Tablets are indicated for treating hypertension, chronic stable angina, vasospastic angina, and to reduce hospitalization risk in patients with documented coronary artery disease. It can be used alone or with other antihypertensive or antianginal agents to manage cardiovascular risk.

    • amlodipine besylate and olmesartan medoxomil

      (Amlodipine besylate and Olmesartan medoxomil)
      Ajanta Pharma USA Inc.
      Usage: Amlodipine and olmesartan medoxomil tablets are indicated for hypertension treatment, either alone or with other antihypertensives, to reduce blood pressure and the risk of cardiovascular events, such as strokes and myocardial infarctions. They may be used as initial therapy for patients likely needing multiple medications to reach blood pressure goals.

    • caduet

      (amlodipine besylate and atorvastatin calcium)
      Pfizer Laboratories Div Pfizer Inc
      Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

    • cardizem cd

      (diltiazem hydrochloride)
      Bausch Health US LLC
      Usage: CARDIZEM CD is indicated for treating hypertension, either alone or with other antihypertensives. It is also used for managing chronic stable angina and angina caused by coronary artery spasm.

    • cardizem la

      (Diltiazem Hydrochloride)
      Bausch Health US LLC
      Usage: CARTIZEM LA is indicated for treating hypertension to lower blood pressure, reducing cardiovascular event risks, including strokes and heart attacks. Additionally, it improves exercise tolerance in patients with chronic stable angina. It can be used alone or in combination with other antihypertensive medications.

    • cartia

      (Diltiazem Hydrochloride)
      Actavis Pharma, Inc.
      Usage: Diltiazem hydrochloride extended-release capsules are indicated for treating hypertension, either alone or with other antihypertensives, and for managing chronic stable angina and angina from coronary artery spasm.

    • diltiazem hydrochloride

      (diltiazem hydrochloride)
      Eugia US LLC
      Usage: Diltiazem hydrochloride injection is indicated for the temporary control of rapid ventricular rate in atrial fibrillation or flutter, and for the rapid conversion of paroxysmal supraventricular tachycardia to sinus rhythm. Continuous ECG monitoring is required, particularly during intravenous infusion.

    • diltiazem hydrochloride

      (Diltiazem Hydrochloride)
      Slate Run Pharmaceuticals, LLC
      Usage: Diltiazem Hydrochloride Extended-Release Tablets are indicated for treating hypertension to lower blood pressure, thereby reducing cardiovascular risks. They also improve exercise tolerance in patients with chronic stable angina. The medication may be used alone or with other antihypertensive drugs for optimal management.